This inventor holds 1 USPTO granted patent. Top assignee: Fred Hutchinson Cancer Center. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Julia Berkson: Innovator in Immunomodulation
Introduction
Julia Berkson is a prominent inventor based in Seattle, WA. She has made significant contributions to the field of immunology, particularly in the modulation of mucosal-associated invariant T (MAIT) cells. Her innovative work aims to enhance therapeutic strategies for conditions associated with inflammation.
Latest Patents
Julia holds a patent titled "Systems and methods for immunomodulation of mucosal-associated invariant T cells." This patent describes systems and methods to modulate the function of MAIT cells in the absence of a T cell receptor (TCR) signal. The implications of her work are profound, as they can be utilized to elucidate the function of MAIT cells and assess potential therapeutic strategies for inflammatory conditions. She has 1 patent to her name.
Career Highlights
Julia Berkson is affiliated with the Fred Hutchinson Cancer Center, where she conducts her research. Her work at this esteemed institution has positioned her as a key player in the field of cancer research and immunotherapy.
Collaborations
Julia collaborates with notable colleagues, including Martin Prlic and Chloe Slichter, who contribute to her research endeavors and enhance the impact of her work.
Conclusion
Julia Berkson's innovative contributions to immunomodulation highlight her role as a leading inventor in the field. Her research not only advances scientific understanding but also opens new avenues for therapeutic interventions.